[与慢性心力衰竭门诊治疗相关的药物干预措施的分析]
Elisée Doffou1, Aminata Coulibaly1, Pascal Danho Abrogoua1
1Unité de pharmacie clinique et thérapeutique, UFR sciences pharmaceutiques et biologiques, université Felix Houphouët-Boigny, 99326 Abidjan, Côte d'Ivoire.
Annales pharmaceutiques francaises
|January 11, 2025
概括
与药物相关的问题,包括坚持问题和药物相互作用,在心力衰竭 (HF) 门诊护理中很常见. 药剂师可以通过监测药物遵守和管理这些与药物相关的问题来改善患者的结果.
科学领域:
- 心脏病学 心脏病学
- 临床药房 临床药房
- 药物经济学 药物经济学
背景情况:
- 心力衰竭 (HF) 门诊管理在药物坚持和潜在的药物相互作用方面提出了挑战.
- 药物干预 (PI) 对于优化治疗和患者结果至关重要.
研究的目的:
- 分析心力衰竭 (HF) 门诊治疗中的药物干预 (PI).
- 确定与毒品有关的问题的流行率和类型 (DRP) 以及PI的影响.
主要方法:
- 在阿比扬心脏病研究所进行了6个月的观察性研究.
- 数据收集的重点是使用标准化工具 (GIRERD,法国临床药学协会编码工具,Calop的算法,CLEO工具) 对治疗坚持,DRP和PI进行数据收集.
主要成果:
- 研究群体的平均年龄为51.4岁,DRP患病率为59%,主要是坚持问题 (43%) 和药物相互作用 (39.7%).
- 关键PI包括"管理方法的优化" (43.6%) 和"治疗监测" (38.1%),医生接受率为80.8%.
- 接受的PI主要被评为具有轻微的临床影响 (60.2%),没有经济影响 (83.8%),以及积极的组织影响 (63.2%).
结论:
- 与药物相关的问题,特别是坚持问题和药物相互作用,在HF门诊管理中很常见.
- 药剂师在通过定期评估治疗坚持和DRP的积极管理来改善HF护理方面发挥着至关重要的作用.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:22Heart Failure Drugs: β-Blockers
314
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:26Heart Failure Drugs: Inotropic Agents
511
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
511
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K